More about United States. Food and Drug Administration. Bureau of Drugs:
| | Books by United States. Food and Drug Administration. Bureau of Drugs: Books in the extended shelves: United States. Food and Drug Administration. Bureau of Drugs: Approved drug products : interim publication. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Bureau of Drugs, 1978) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Approved Rx drug products. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Bureau of Drugs :, 1980), also by National Center for Drugs and Biologics (U.S.) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Background material for the development of the Food and Drug Administration's recommendations on thyroid-blocking with potassium iodide (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Bureau of Radiological Health ;, 1981), also by Jerome A Halperin and United States. Bureau of Radiological Health (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: General considerations for the clinical evaluation of drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: General considerations for the clinical evaluation of drugs in infants and children. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for detection of hepatotoxicity due to drugs and chemicals (U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health ;, 1979), also by Earl C. Chamberlayne, Carroll Moton Leevy, and Charles S. Davidson (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of antacid drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Division of Cardio-Renal Drug Products, Bureau of Drugs ;, 1978) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of anti-infective drugs (systemic) (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children) (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1988) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of anti-inflammatory drugs (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1978) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of antianxiety drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of anticonvulsant drugs (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of antidepressant drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of general anesthetics. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of local anesthetics. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of radiopharmaceutical drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977) (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Guidelines for the clinical evaluation of radiopharmaceutical drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1981), also by United States Food and Drug Administration (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Interim trade name index of all prescription drugs in the drug efficacy study <May 1, 1976- > (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Bureau of Drugs., in the 1st century), also by United States. Food and Drug Administration. Drug Efficacy Study Implementation Project, Education United States. Dept. of Health, and United States Public Health Service (page images at HathiTrust) United States. Food and Drug Administration. Bureau of Drugs: Lipid-altering agents in adults and children (United States Government Printing Office, 1980), also by United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products and United States Department of Health and Human Services (page images at HathiTrust)
Find more by United States. Food and Drug Administration. Bureau of Drugs at your library, or elsewhere.
|